# Cell-free RNA signatures derived from the tumor microenvironment predict outcomes of CAR T therapy in large B cell lymphoma

Source: [cell.com](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00593-8?rss=yes) · 2026-11-18 · Medicine
Page: https://themorning.science/story/cell-free-rna-signatures-derived-from-the-tumor-microenvironment-predict-outcome-90aa9ed4337f96b7
Kind: research · Impact: medium

## In brief

- Plasma cell-free RNA collected before anti-CD19 CAR T cell infusion predicts long-term treatment response in large B cell lymphoma, according to Loy et al.
- The study uses tumor microenvironment-derived archetypes and unbiased feature discovery to identify these RNA signatures.
- The authors report that plasma cell-free RNA captures signals from the tumor microenvironment.

## Why it matters

A blood-based RNA signature measured before infusion could help clinicians anticipate which lymphoma patients are likely to respond durably to CAR T therapy, without needing tumor biopsies.

## Timeline

- 2026-11-18: Study published in Cell Reports Medicine

## Coverage

- [Cell-free RNA signatures derived from the tumor microenvironment predict outcomes of CAR T therapy in large B cell lymphoma](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00593-8?rss=yes) — cell.com, 2026-11-18

Tags: cell-free rna, car t therapy, lymphoma, biomarkers, liquid biopsy, tumor microenvironment

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
